68Ga-DOTA-Exendin PET-MRI Fusion Imaging in a Case of Insulinoma.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
pubmed:
21
5
2019
medline:
16
8
2019
entrez:
21
5
2019
Statut:
ppublish
Résumé
Persistent hyperinsulinemic hypoglycemia in adults is most commonly caused by insulinomas, which pose a diagnostic challenge to physicians, surgeons, and radiologists and require multimodality imaging for precise localization and staging. PET tracers such as F-FDOPA and glucagon-like peptide 1 receptor analogs have been used for imaging insulinomas. Glucagon-like peptide 1 receptor analogs have recently shown promising results in preoperative localization of these tumors, as all insulinomas express glucagon-like peptide 1 receptors. Ga-DOTA-Exendin PET and MRI done in the present case helped in precise localization and management of the culprit lesion, whereas contrast-enhanced CT and F-FDOPA PET failed to do so.
Identifiants
pubmed: 31107750
doi: 10.1097/RLU.0000000000002620
doi:
Substances chimiques
68Ga-DOTA-exendin-4
0
Organometallic Compounds
0
Peptides
0
Radiopharmaceuticals
0
fluorodopa F 18
2C598205QX
Dihydroxyphenylalanine
63-84-3
Types de publication
Case Reports
Journal Article
Langues
eng